Managing heartburn and reflux in primary care.
Journal
JAAPA : official journal of the American Academy of Physician Assistants
ISSN: 1547-1896
Titre abrégé: JAAPA
Pays: United States
ID NLM: 9513102
Informations de publication
Date de publication:
13 Feb 2024
13 Feb 2024
Historique:
medline:
13
2
2024
pubmed:
13
2
2024
entrez:
13
2
2024
Statut:
aheadofprint
Résumé
This article describes an algorithmic approach to caring for patients presenting with heartburn and reflux, including empiric treatment with acid-suppression therapy and a data-driven approach to diagnostic testing. This article also reviews the efficacy and safety profile of the widely available and commonly used proton pump inhibitors. Refining our approach to diagnostic testing can reduce time to diagnosis, better control patients' symptoms, and limit complications of longstanding disease.
Identifiants
pubmed: 38349081
doi: 10.1097/01.JAA.0001005620.54669.f4
pii: 01720610-990000000-00100
doi:
Types de publication
Journal Article
Langues
eng
Informations de copyright
Copyright © 2024 Wolters Kluwer Health | Lippincott Williams & Wilkins.
Références
Peery AF, Crockett SD, Murphy CC, et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2021. Gastroenterology. 2022;162(2):621–644.
Katz PO, Dunbar KB, Schnoll-Sussman FH, et al. ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2022;117(1):27–56.
Delshad SD, Almario CV, Chey WD, Spiegel B. Prevalence of gastroesophageal reflux disease and proton pump inhibitor-refractory symptoms. Gastroenterology. 2020;158(5):1250–1561.
Li N, Yang W-L, Cai M-H, et al. Burden of gastroesophageal reflux disease in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease study 2019. BMC Public Health. 2023;23(1):582.
Targownik LE, Fisher DA, Saini SD. AGA clinical practice update on de-prescribing of proton pump inhibitors: expert review. Gastroenterology. 2022;162(4):1334–1342.
Dent J, Vakil N, Jones R, et al. Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond study. Gut. 2010;59(6):714–721.
Bytzer P, Jones R, Vakil N, et al. Limited ability of the proton-pump inhibitor test to identify patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2012;10(12):1360–1366.
Yadlapati R, Gyawali C, Pandolfino J, et al. AGA clinical practice update on the personalized approach to the evaluation and management of GERD: expert review. Clin Gastroenterol Hepatol. 2022;20(5):984–994.
Karatay E, Gok MA, Javadov M. Measurement of hiatal surface area and other hiatus oesophageal diameters at computed tomography imaging in patients with gastroesophageal reflux disease and its relationship with hiatal hernia. J Minim Access Surg. 2021;17(4):537–541.
Odiase E, Schwartz A, Souza RF, et al. New eosinophilic esophagitis concepts call for change in proton pump inhibitor management before diagnostic endoscopy. Gastroenterology. 2018;154(5):1217–1221.
Gyawali C, Kahrilas PJ, Savarino E, et al. Modern diagnosis of GERD: the Lyon Consensus. Gut. 2018;67(7):1351–1362.
Gyawali C, Carlson D, Chen J, et al. ACG clinical guidelines: clinical use of esophageal physiologic testing. Am J Gastroenterol. 2020;115(9):1412–1428.
Ness-Jensen E, Hveem K, El-Serag H, Lagergren J. Lifestyle intervention in gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2016;14(2):175–182.
Waghray A, Waghray N, Perzynski AT, et al. Optimal omeprazole dosing and symptom control: a randomized controlled trial (OSCAR trial). Dig Dis Sci. 2019;64(1):158–166.
Wang W-H, Huang J-Q, Zheng G-F, et al. Head-to-head comparison of H2-receptor antagonists and proton pump inhibitors in the treatment of erosive esophagitis: a meta-analysis. World J Gastroenterol. 2005;11(26):4067–4077.
Khan M, Santana J, Donnellan C, et al. Medical treatments in the short term management of reflux oesophagitis. Cochrane Database Syst Rev. 2007;(2):CD003244.
Fass R, Sontag SJ, Traxler B, Sostek M. Treatment of patients with persistent heartburn symptoms: a double-blind, randomized trial. Clin Gastroenterol Hepatol. 2006;4(1):50–56.
Graham DY, Tansel A. Interchangeable use of proton pump inhibitors based on relative potency. Clin Gastroenterol Hepatol. 2018;16(6):800–808.
Fackler WK, Ours TM, Vaezi MF, Richter JE. Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough. Gastroenterology. 2002;122(3):625–632.
Rettura F, Bronzini F, Campigotto M, et al. Refractory gastroesophageal reflux disease: a management update. Front Med. 2021;8:Article 765061.
Farrell B, Pottie K, Thompson W, et al. Deprescribing proton pump inhibitors: evidence-based clinical practice guideline. Can Fam Physician. 2017;63(5):354–364.
Gralnek IM, Dulai GS, Fennerty MB, Spiegel B. Esomeprazole versus other proton pump inhibitors in erosive esophagitis: a meta-analysis of randomized clinical trials. Clin Gastroenterol Hepatol. 2006;4(12):1452–1458.
Vonoprazan prescribing information. Buffalo Grove, IL: Phantom Pharmaceuticals; 2023. www.accessdata.fda.gov/drugsatfda_docs/label/2023/215151s000lbl.pdf. Accessed December 5, 2023.
Farrell B, Lass E, Moayyedi P, et al. Reduce unnecessary use of proton pump inhibitors. BMJ. 2022;379:e069211.
Moayyedi P. How to advise patients on the risk of chronic proton pump inhibitor therapy. Curr Opin Gastroenterol. 2020;36(4):317–322.
Moayyedi P, Eikelboom JW, Bosch J, et al. Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin. Gastroenterology. 2019;157(3):682–691.
Longstreth GF. Internists' misconceptions about PPIs: increasing knowledge and implementing guidelines. Am J Gastroenterol. 2020;115(5):681–682.
Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(7):2160–2236.
Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. 2021;99(3S):S1–S87.